CYTEK BIOSCIENCES INC
Cytek Biosciences (CTKB) develops spectral flow cytometry systems, reagents and analysis software used by research institutions, biopharma and clinical laboratories. Its instruments aim to measure many parameters per cell, supporting deeper immunophenotyping and single‑cell studies. The company’s revenue mix commonly combines one‑off instrument sales with recurring consumables and software licences, which can support steadier revenue as the installed base expands. Growth drivers include broader adoption of spectral cytometry, new product introductions and partnerships with pharmaceutical and diagnostic customers. Key risks are strong competition from established instrument makers, continued need for R&D investment, supply‑chain and manufacturing execution, and sensitivity to research spending cycles. As a small‑cap company (market capitalisation roughly $530m), CTKB may exhibit greater volatility and lower liquidity than larger peers. This summary is general educational information only and not personal advice; values can fall as well as rise.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Cytek's stock with a target price of $5.25, indicating potential growth.
Financial Health
Cytek Biosciences is performing well with solid revenue, cash generation, and profitability indicators.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CTKB
Cell & Gene Therapy Logistics
This carefully curated collection features companies providing the essential infrastructure that makes advanced cell and gene therapies possible. Selected by expert analysts, these stocks represent the "picks and shovels" of the biotech revolution—giving you exposure to regenerative medicine's growth without the direct risks of clinical trials.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Adoption of Spectral Cytometry
Spectral cytometry can enable higher‑parameter analysis, so broader adoption could support long‑term growth — though customer uptake and competition will influence outcomes.
Recurring Consumables Revenue
Consumables and software licences offer recurring revenue potential that can stabilise sales beyond instrument purchases, yet revenue can vary with research budgets.
Market & Competition
The addressable market spans academic, clinical and pharma customers, but Cytek faces established players and execution challenges; investors should watch commercial traction closely.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
